Breaking News3 years ago
Biogen shares jump 4.7% premarket on hopes for its Alzheimer’s treatment lecanemab
[ad_1] Biogen Inc. shares BIIB, +5.07% rose 4.7% in premarket trade Monday, after MorphoSys and partner Roche said a trial of a treatment for Alzheimer’s disease...
